Evidence map›Paper›PMID 39866557›Full record

ArticlePeerJ2025

Altered expression of miRNA profile in peripheral blood mononuclear cells following the third dose of inactivated COVID-19 vaccine.

Guanguan Qiu, Ruoyang Zhang, Huifeng Qian, Ruoqiong Huang, Jie Xia, Ruoxi Zang, Zhenkai Le, Qiang Shu, Jianguo Xu, Guoping Zheng and 1 more

Abstract read
In one paragraph

Article in PeerJ, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Guanguan Qiu *Shaoxing Second Hospital, Shaoxing, Zhejiang, China.
Ruoyang Zhang *Children's Hospital of Zhejiang University School of Medicine, Hangzhou, China.
Huifeng QianShaoxing Second Hospital, Shaoxing, Zhejiang, China.ORCID 0009-0000-1110-5666
Ruoqiong HuangChildren's Hospital of Zhejiang University School of Medicine, Hangzhou, China.
Jie XiaChildren's Hospital of Zhejiang University School of Medicine, Hangzhou, China.
Ruoxi ZangChildren's Hospital of Zhejiang University School of Medicine, Hangzhou, China.
Zhenkai LeChildren's Hospital of Zhejiang University School of Medicine, Hangzhou, China.
Qiang ShuChildren's Hospital of Zhejiang University School of Medicine, Hangzhou, China.
Jianguo XuShaoxing Second Hospital, Shaoxing, Zhejiang, China.
Guoping ZhengShaoxing Second Hospital, Shaoxing, Zhejiang, China.
Jiangmei WangChildren's Hospital of Zhejiang University School of Medicine, Hangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19 vaccination is the most effective strategy for preventing severe disease and death. Inactivated vaccines are the most accessible type of COVID-19 vaccines in developing countries. Several studies, including work from our group, have demonstrated that the third dose (booster vaccination) of inactivated COVID-19 vaccine induces robust humoral and cellular immune responses. The present study aimed to examine miRNA expression profile in participants who received a homologous third dose of the CoronaVac vaccine. Samples of peripheral blood mononuclear cells (PBMCs) were collected from healthcare volunteers both before and 1-2 weeks after the booster dose. miRNA microarray analysis in a discovery cohort of six volunteers identified 67 miRNAs with differential expression. Subsequently, the expression of six miRNAs related to immune responses was examined in a validation cohort of 31 participants

Indexed as

COVID-19COVID-19 VaccinesLeukocytes, MononuclearMicroRNAsAdultFemaleHumansImmunization, SecondaryMaleMiddle AgedSARS-CoV-2Vaccines, InactivatedCOVID-19 VaccinesMicroRNAsVaccines, InactivatedCoronaVacCOVID-19Immune responseInactivated vaccineMicroRNAPeripheral blood mononuclear cells

Identifiers

PMID39866557
PMCPMC11760199

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.